A detailed history of Sweeney & Michel, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sweeney & Michel, LLC holds 9,426 shares of ABBV stock, worth $1.67 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
9,426
Previous 9,121 3.34%
Holding current value
$1.67 Million
Previous $1.53 Billion 16.14%
% of portfolio
0.7%
Previous 0.65%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$163.84 - $199.33 $49,971 - $60,795
305 Added 3.34%
9,426 $1.78 Billion
Q2 2024

Jul 10, 2024

BUY
$154.79 - $180.76 $8,823 - $10,303
57 Added 0.63%
9,121 $1.53 Billion
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $50,183 - $57,179
-314 Reduced 3.35%
9,064 $1.46 Billion
Q3 2023

Nov 09, 2023

BUY
$133.59 - $154.65 $8,015 - $9,279
60 Added 0.64%
9,378 $1.33 Billion
Q2 2023

Aug 09, 2023

SELL
$132.51 - $164.9 $70,627 - $87,891
-533 Reduced 5.41%
9,318 $1.39 Billion
Q1 2023

Jun 07, 2023

BUY
$144.61 - $166.54 $1.42 Million - $1.64 Million
9,851 New
9,851 $1.33 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sweeney & Michel, LLC Portfolio

Follow Sweeney & Michel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sweeney & Michel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sweeney & Michel, LLC with notifications on news.